decreased tumor incidence_Kitl<Sl-d>/Kitl<Sl-d>,Tg(Mt1-RET)304Ina/0

http://metadb.riken.jp/0002052IBALBcC57BL6DBA2KitlSldKitlSldTgMt1RET304Ina0KitlSldTgMt1RET304Ina

decreased tumor incidence_Kitl<Sl-d>/Kitl<Sl-d>,Tg(Mt1-RET)304Ina/0

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• kit ligand
  http://metadb.riken.jp/db/mgi_rdf/MGI:96974
• transgene insertion 304, Izumi Nakashima
  http://metadb.riken.jp/db/mgi_rdf/MGI:3039780

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Kitl<Sl-d>/Kitl<Sl-d>,Tg(Mt1-RET)304Ina/0

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Kitl<Sl-d>|Tg(Mt1-RET)304Ina

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: BALB/c * C57BL/6 * DBA/2

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• decreased tumor incidence
  http://purl.obolibrary.org/obo/MP_0002052

文献

http://purl.org/net/cito/citesAsAuthority

• Masashi. Kato, et.al., c-Kit-targeting immunotherapy for hereditary melanoma in a mouse model., Cancer research, 2004, 64
  http://rdf.ncbi.nlm.nih.gov/pubmed/14871802